Spero Therapeutics Expands Stock Incentive Plan for Growth
Company Announcements

Spero Therapeutics Expands Stock Incentive Plan for Growth

An announcement from Spero Therapeutics (SPRO) is now available.

Spero Therapeutics, Inc. stockholders have greenlit an expansion of the company’s 2017 Stock Incentive Plan, adding 3 million more shares available for issuance. Details on the plan’s specifics were outlined in the Proxy Statement for the 2024 Annual Meeting, emphasizing the company’s commitment to leveraging stock incentives for growth and rewarding performance.

See more data about SPRO stock on TipRanks’ Stock Analysis page.

Related Articles
Brian AndersonSPRO Upcoming Earnings Report: What to Expect?
TheFlySpero Therapeutics price target lowered to $5 from $7 at H.C. Wainwright
TheFlyBiotech Alert: Searches spiking for these stocks today
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App